Remove Drug Development Remove Interoperability Remove Leadership Remove Mental health
article thumbnail

Where are HealthTech's soft landing M&A deals in today's market?

Lloyd Price

Interoperability and data analytics: Merging companies with expertise in connecting disparate healthcare systems and generating actionable insights can be valuable. AI and machine learning: Companies with advanced AI solutions for tasks like drug discovery, clinical trial optimisation, and personalised medicine can be attractive targets.

article thumbnail

Key trends expected to shape Pain Management and Adherence markets in 2024 and beyond

Lloyd Price

Corporate Development for Healthcare Technology companies in EMEA Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors.

article thumbnail

Uses of AI in Healthcare – 2024 Health IT Predictions

Healthcare IT Today

Dr. Carl Marci, Chief Psychiatrist and Managing Director of Mental Health at OM1 The industry needs commitment, not hype related to AI in mental health: As we move into the new year, the industry will continue the hype-cycle around the myriad uses of AI in mental health. Carolyn Ward, M.D.

Health IT 109